Long-term disease stabilization following treatment with erlotinib in heavily pretreated patients with wild-type epidermal growth factor receptor non-small-cell lung carcinoma: Two case reports

Lung adenocarcinomas carrying epidermal growth factor receptor (EGFR) mutations have been identified as a unique group of entities that depend on EGFR for their proliferation and metastasis. The introduction of reversible EGFR tyrosine kinase inhibitors, such as erlotinib, has significantly affected...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Mol Clin Oncol
Autori principali: Sakellakis, Minas, Koutras, Angelos, Pittaka, Maria, Tsitsopoulos, Efstathios, Kalofonou, Fotini, Kalofonos, Haralabos P.
Natura: Artigo
Lingua:Inglês
Pubblicazione: D.A. Spandidos 2016
Soggetti:
Articles
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5228472/
https://ncbi.nlm.nih.gov/pubmed/28105360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2016.1036
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi